Vanguard Ftseem (VFEM) Quote

Check Dave's 23...GL

They posted in their latest tweet they know they will have to answer questions about CNNA. As much as I am annoyed by you I hope you jump on and ask your questions.

Lilly’s new drug

Of the participants who took donanemab three people died while taking the drug after developing ARIA, micro-hemorrhages known as amyloid-related imaging abnormalities.

https://www.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html#:~:tex

That’s a pretty accurate post

Savoy Brown - Why Did You Hoodoo Me

https://www.youtube.com/watch?v=ce31SfWEkmc

There killing it
$aagc

I heard a talk by a Pharma pricing consultant: in Europe the government is the primary payer, so pricing is constrained by govt budgets. They negotiate rather aggressively, so Pharma usually gets quite a bit less than they do in the US. The advantage Anavex has is that there is no other effective

I'm so sorry to hear that about your uncle. My Mom is in the end stages of Dementia and on Hospice care. She is withering away too, and she doesn't have much longer to live. It's a terrible disease that I wouldn't wish on anyone.

If your in USA , you can't buy. It's in Expert market

LEDS 10Q expected JULY11
https://investorshub.advfn.com/uimage/uploads/2024/7/7/wjqtqIMG_9392.gif

I predict the next nine months will be the months that will be the most prestigious months of elite so far with the most approvals and news releases.

We may see the stock price go as up as $1. Yes 500% up

I’m intrigued by the timing of the 2nd Qtr report and the BRAVE poster at AAIC 2024 conference. My fever dream is Amarin announces a collaboration with VA and UW Madison to conduct a larger trial based on encouraging results from BRAVE.

They are not CNNA so they will not respond to any of those questions. If CNNA is bad there is absolutely nothing I can expect from Prodigy, won't be waisting my time. Just want CNNA out, anything that Prodigy says or does is irrelevant until CNNA is out of EM so why even bother.

100 per cent in 5 years. Thats better than Warren Buffet

I’ve done very very well over the years. I buy OTC’s and have some 6 big boards. I think I’m all set with my shares here, but ya never know. I may buy more when Q2 is posted.

10baggerz
Monday, July 10, 2023 12:31:22 AM
UK approval would change literally EVERYTHING for NWBO and make it EXPONENTIALLY harder (more expensive) for shorts to manipulate the price.
1. Everyone with GBM will immediately demand it.
2. Every medical professional will imm

Indyterp… can you elaborate on your comment?
What do you mean the deal is done?

Kyle wears more gold than he has found in 15 years lol ..
I'm hoping new tech is worthy, but doesn't appear to find anything in Juno, even though they have found many targets with non ferrous metals.
Buy the new tech is suppose to identify gold and silver.
Guess they haven't fou

Newman - Check the figure again. Add only three zeros after the number, assume 64 is correct.
plus the defendants in their very first submission self admitted to spoofing and said they only profitted about $64M

Project 2025,trump remaking America, you better be white.

387 days being stuck because you don’t know how to diversified want to grow a stock trading empire. Sign me up.

UAE update Monday?

In my experience, Canadian short sellers don't use FINRA member firms, because FINRA is an American institution, so they don't report their short positions to any FINRA database.

I think DBMM is heavily shorted because when a company makes it to the caveat emptor list that usually me

Rayo: “Replacing 10% of the polyester market with a fiber that beats polyesters properties, is some how tough to envision? I really couldn't say how this will eventually play out specifically, but production will happen if there is money to be made.”

Producing 6 million metric tons of